6.46 5.35 1.11 20.82 13.46 9.99 3.47 34.75 Drugs and medical supplies 0.11 0.24 (0.13) (54.12) 0.29 0.44 (0.15) (33.98) Other supplies 0.11 0.41 (0.29) (71.78) 0.34 0.58 (0.24) (41.55) X-ray 1.44 2.95

set robust environmental standards for the market. • As many of you know, IFC is at the forefront of creating green financing markets in Asia, including Thailand. Through our recent sustainable

membership. By providing high quality technical assistance, education and training, and research to its members and other regulators, IOSCO seeks to build sound global capital markets and a robust global

and accuracy of the disclosed information. Moreover, robust disciplinary actions should be set out against those who fail to comply with the firms’ ethical requirements. In a long run, audit firms might

232.45 210.38 22.07 10.49 Medical service 5.35 3.91 1.44 36.72 9.99 6.50 3.49 53.69 Drugs and medical supplies 0.24 0.25 (0.01) (5.90) 0.44 0.47 (0.03) (6.15) Other supplies 0.41 0.27 0.13 48.17 0.58 0.65

% Sep. 30, 2019 Sep. 30, 2018 Amoun % Medical treatment 127.20 115.77 11.43 9.87 359.65 326.15 33.50 10.27 Medical service 7.21 4.58 2.62 57.22 17.20 11.08 6.11 55.15 Drugs and medical supplies 0.22 0.26

create a diversified earning stream via its HVA portfolio. This portfolio, which accounted for 52% of overall core EBITDA, has enabled the Company to de- liver robust earnings on a sustained basis. The HVA

higher revenue per visit of non-social security category but also from the efficient cost control of medicine and supplies as well as staff. Administrative Expenses Administrative expenses decreased by 13

-on-period basis was attributable to the Company having some costs in personnel, doctor fee, drugs and medical supplies, depreciation, electricity charge, medical utensils costs, and medical consumable

of Baht 21.0 million or 44.3%. The increase in total expenses was mainly from increase in staff cost, medical supplies, doctor fee and doubtful debts expense. - Income tax for Q2/2017 in the amount of